Borghaei H, Ciuleanu TE, Lee JS, Pluzanski A, et al. Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small cell lung cancer: a pooled analysis. Ann Oncol 2022 Nov 19:S0923-7534(22)04740-8. doi: 10.1016/j.annonc.2022.
PMID: 36414192